RNA inhibitors | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

20,011 results for “RNA inhibitors”

Error parsing response

RNA Polymerase I Inhibitors Emerge as Promising Cancer Therapy with Pindnarulex Leading Clinical Development

Novel Therapies Show Promise in Treating Cardiac Amyloidosis

WiNK Therapeutics Targets Diabetes with RNA Aptamer Technology

Drug Hunter Highlights Key Pharmaceutical Patents and Clinical Updates from Late 2024

STORM Therapeutics Initiates First-in-Class RNA Modification Therapy Combination Trial with Checkpoint Inhibitor

Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics to Advance RNA-LNP Therapeutics

Altamira Therapeutics Advances RNA Delivery Platform Through Strategic Spin-Off and Circular RNA Innovation

iOncologi Secures Key Patent for RNA-Based Cancer Immunotherapy as Studies Link COVID-19 mRNA Vaccines to Enhanced Checkpoint Inhibitor Response

Next-Generation RNA Technologies Promise Longer-Lasting Therapeutics Beyond mRNA

Page 1 of 599